Evaluation of efficacy of levetiracetam on cognitive symptoms in schizophrenic patients
Phase 2
Recruiting
- Conditions
- schizophrenic.Schizophrenia
- Registration Number
- IRCT20101130005280N32
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
6-month to 10-year history of schizophrenia
Have a normal IQ
Do not be in the acute phase of schizophrenia.
The patient do not take anticholinergic and benzodiazepine medications
do not history of drug use in the past 6 months (except nicotine)
Do not be pregnant or breastfeeding (Pregnancy Detection Based on BHCG Pregnancy Test)
Exclusion Criteria
Lack of consent for participation in the study
Serious medical illness
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cognitive function. Timepoint: At baseline, weeks 4 and 8. Method of measurement: Wisconsin questionnaire, Stroop test.;Quality of Life. Timepoint: At baseline, weeks 4 and 8. Method of measurement: The Positive and Negative syndrome Scale.
- Secondary Outcome Measures
Name Time Method